{"id":"W2947775394","doi":"10.1200/jco.19.00934","title":"Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1185,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Pembrolizumab; Overall survival; Lung cancer; Safety profile; Phases of clinical research; Survival rate; Cancer; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001846958,0.0004583306,0.0006459915,0.0002604552,0.0002612264,0.0005700823,0.0003765298,0.0005607826,0.0008561437],"category_scores_gemma":[0.00118641,0.0001548807,0.001121918,0.0002659355,0.0002796113,0.0005381521,0.00029578,0.000968816,0.0002022866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006727204,"about_ca_system_score_gemma":0.00040797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00060029,"about_ca_topic_score_gemma":0.001252929,"domain_scores_codex":[0.99961,0.0001675237,0.00003226772,0.00007563266,0.00006549234,0.00004900581],"domain_scores_gemma":[0.9991114,0.0001658844,0.0003421814,0.00006538136,0.00006428594,0.0002508247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1815963,0.007561227,0.6841184,0.0007813181,0.005541081,0.0004598277,0.0003411403,0.003834673,0.009730494,0.0001605794,0.006412074,0.09946293],"study_design_scores_gemma":[0.02610672,0.05308412,0.9097929,0.0001217845,0.00266117,0.0007398803,0.0001253774,0.002311574,0.001623115,0.0001451567,0.00324658,0.00004157398],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956253,0.002592132,0.0002001723,0.0001627139,0.00003254167,0.00005949845,0.0008404686,0.00001334101,0.0004737913],"genre_scores_gemma":[0.9961199,0.0007111621,0.0001275062,0.0002237841,0.00005705197,0.00005939916,0.002417395,0.000004097214,0.0002798524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001846958,"threshold_uncertainty_score":0.009767771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04314214802703654,"score_gpt":0.41046673368768,"score_spread":0.3673245856606435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}